Log in to save to my catalogue

TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enh...

TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enh...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6192054

TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy

About this item

Full title

TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy

Publisher

England

Journal title

Nature biomedical engineering, 2018-08, Vol.2 (8), p.578-588

Language

English

Formats

Publication information

Publisher

England

More information

Scope and Contents

Contents

Tumour-associated macrophages are abundant in many cancers, and often display an immune-suppressive M2-like phenotype that fosters tumour growth and promotes resistance to therapy. Yet, macrophages are highly plastic and can also acquire an anti-tumorigenic M1-like phenotype. Here, we show that R848, an agonist of the toll-like receptors TLR7 and T...

Alternative Titles

Full title

TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6192054

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6192054

Other Identifiers

E-ISSN

2157-846X

DOI

10.1038/s41551-018-0236-8

How to access this item